Fate Therapeutics Inc (NASDAQ:FATE) recently issued a statement that it has enrolled it first patient for the second phase of this study. The primary aim of the PUMA study is to assess the efficacy and safety of PROHEMA in a randomized, controlled environment for patients that are under treatment for hematopoietic stem cell or HSC…
Hewlett-Packard Co. (NYSE:HPQ) has unveiled a new cloud encryption tool for customers to protect sensitive data, Infotech Lead reported Thursday. HP designed the Atalla cloud encryption system to secure data residing in the cloud and on enterprise premises such as emails, payment data and electronic health records, according to the report. Hewlett-Packard Company (NYSE:HPQ) stock…
The chase for the podium ensues as the 2014 MotoGP calendar heads to Australia! On the Internet or on TV, MotoGP fans can watch today’s race from smartphones, tablets and laptops thanks to links provided below and on national TV channels. If you miss the Australian MotoGP Grand Prix live stream, you can watch its…
The card companies, banks and payment processors cooperate together to charge a good chunk of fees both to cover the cost of fraud and to protect against it. But can bitcoin offer better, or at the very least lower-cost, fraud protection for merchants and consumers? It’s almost essential today for merchants to accept credit or…
Resort, and gaming products operator Boyd Gaming (NYSE:BYD) vaulted higher by 16.5% after hedge fund Elliott Management disclosed in a regulatory filing that it had obtained 4.99% of Boyd’s outstanding shares and had additional exposure of 2.05% through derivatives. Boyd Gaming Corporation (NYSE:BYD) stock performance was 16.53% in last session and finished the day at…
Dyax Corp (NASDAQ:DYAX) shares rose 8.1% to $10.99, their highest price since mid-2004, after positive Phase 1a study results of DX-2930, a treatment for hereditary angioedema attacks. The first-in-human clinical study of DX-2930 met all objectives of assessing safety, tolerability and pharmacokinetics and showed it well tolerated at all dose levels. Pharmacokinetic results demonstrated that…
Tech Analysis & Market News